![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26625-26628, September 17, 1999
From the Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio 44106
Principally through the efforts of
crystallographers, we are being presented with an ever expanding atomic
view of the biological world. Although this brings into focus many
questions regarding the mysteries of function, techniques are needed
that facilitate the transition in our understanding from structure to
function. Raman spectroscopy is one of these; because the Raman effect
involves an intimate interplay between atomic positions, electron
distribution, and intermolecular forces, it sits at the bridgehead
between structure and function. Thus, the Raman technique can answer
questions that lie at the heart of issues such as ligand macromolecule
recognition and enzymatic catalysis. Raman spectroscopy involves
analyzing the scattered photons from a laser beam focused into the
sample solution (1). The inelastic scattered photons (the Raman
spectrum) provide information on molecular vibrations that, in turn,
yield data on molecular conformation and environment. At its most
effective, Raman spectroscopy can provide exquisite detail from an
important site in a much larger macromolecular complex. Although Raman
was first applied to the definition of biological molecules in the 1930s (2), the giant has remained drowsy due the difficulties both in
obtaining high quality data and in interpreting those data.
Considerable advances have been made in these areas in the past few
years, and the giant is stirring!
A major goal of this review is to provide biochemists with enough
information to determine whether the Raman technique could provide
structural insights into their systems. The specific issues addressed
are which type of systems are amenable to study and what information
could be obtained. Practically, present-day sample requirements are for
20 µl of clear solution, where the target molecule is in the 100-300
µM range. Because the number of vibrational modes of a
molecule is 3n Raman spectroscopy is beginning to fulfill its potential to contribute
to structural biology because the three roadblocks that impeded its
application to biological systems have been all but removed. These were
low sensitivity, interference from fluorescence background, and
problems with data interpretation. Sensitivity has increased several
orders of magnitude with the corresponding decrease in concentration
requirements because of advances in optical filters and photon
detectors (6). Fluorescence interference is now minimized by using
deep-red excitation in the 650-800 nm range, made possible by the
advent of photon detectors with high efficiency in this region (7).
Problems with interpreting Raman spectra have receded with the
availability of "friendly" software packages (8) and ever
increasing computational power that enable us to calculate, ab
initio, the Raman spectra of mid-sized molecules (of the size of
many ligands or co-factors found at biological sites). Interpretation
is further strengthened by a comparison of the calculated and
experimental shifts in Raman peak positions when a molecule is
substituted with stable isotopes. Recently, this approach has been used
to characterize hydrogen bonding in a complex of adenosine deaminase
with a transition state analogue (9) and to discriminate between
different protonation states of dihydrofolate binding to dihydrofolate
reductase (10).
The Raman spectrum of 5-methyl thienylacrylic acid
(5-MTA)1 is shown in Fig.
1; the 5-MTA entity has been used
extensively as a probe of protease active sites (3, 11, 12). The
spectrum was obtained by focusing a laser beam into a solution in
methanol and by analyzing the scattered light 90° to the direction of
the beam using a Raman spectrometer. A small percentage of the
scattered photons exchange energy with the vibrational energy levels
(or, crudely, the "vibrations") of the molecules in solution. Thus, by analyzing the scattered photons information on the vibrational motions of atoms in molecules is obtained. These motions are a function
of molecular conformation, of the distribution of electrons in the
chemical bonds, and of the molecular environment. Thus, interpretation
of the Raman spectrum provides information on all these factors. This
is the underlying principle behind using Raman spectroscopy for
defining the detailed chemistry of molecules at biological sites
(1).
![]()
INTRODUCTION
TOP
INTRODUCTION
What Is Raman and...
Evolving Technology Increases...
Limitations and Prospects
REFERENCES
6, where n is the number of
atoms, the complete Raman spectrum of a macromolecule is exceedingly complex. Thus, Raman is most suited to systems where it is possible to
focus upon a small region of interest, e.g. a
ligand-receptor or enzyme-substrate binding site. Historically, this
condition was achieved by using resonance Raman spectroscopy (1) to
obtain the intensity-enhanced spectra from chromophores at specific
sites in macromolecules. Recent technical advances mean that similar information can now be gleaned from non-chromophoric systems, markedly
broadening the application of the technique. The information obtained
can be very detailed, exceeding the level of resolution found in x-ray
or NMR analyses (3-5). In addition to providing structural data, the
Raman spectrum can also reveal changes in the distribution of electrons
in a bound ligand and details of active site-ligand interactions, such
as hydrogen bonding strengths.
![]()
What Is Raman and What Does It Tell You?
TOP
INTRODUCTION
What Is Raman and...
Evolving Technology Increases...
Limitations and Prospects
REFERENCES

View larger version (18K):
[in a new window]
Fig. 1.
The normal (non-resonance), 647.1 nm excited,
Raman spectrum of 5-MTA. The positions of the peaks are in units
of wave numbers (cm
1) and represent the difference in
energy between the incoming and scattered photons.
With present day computational power, commercially available software
packages allow us to undertake high level quantum mechanical calculations on molecules such as 5-MTA acid and to predict the stable
conformational states for this molecule as well as the infrared and
Raman active vibrations (13). Such calculations put interpretation of
the data on a sure footing. They also reveal the complex nature of
vibrational spectra; many peaks are due to vibrational motions that
include contributions from many atoms in the molecule. However, some
vibrations are more or less localized in molecular groupings and three
such are indicated in Fig. 1 (the C=O and C=C stretching vibrations and
the breathing-type motion of the thienyl ring). We will see below how
the carbonyl peak can provide detailed chemical information on the
chemistry of this group in serine protease active sites. In addition,
the C=C stretch and ring modes can be used to follow the redistribution of
-electrons for 5-MTA in cysteine protease active sites (11), and
marker bands in the 1000-1200 cm
1 region give the
conformation, cis or trans, about the =C-C=O single bond (13, 14).
The absorption spectrum of the 5-MTA chromophore shows a maximum in the near UV at 324 nm. If a laser wavelength far from this electronic transition, e.g. near 650 nm, is used to generate the Raman spectrum the resulting spectrum is relatively weak. If, however, we use an excitation wavelength near 330 nm the coincidence between this and the absorption band leads to large (103 or more) intensity enhancement. This is the resonance Raman (RR) effect, and because of its high intensity it has been the method most used for obtaining vibrational spectra at biological sites. RR plays a key role in obtaining data from natural chromophoric sites such as occur in heme (15-17) and metalloproteins (18). Moreover, time-resolved RR is a powerful means of following changes at a chromophoric site in a rapidly evolving system such as cytochrome oxidase (19) or a peptide in the early stages of folding (20). However, for stable or slowly evolving systems, increases in sensitivity now allow us to obtain Raman difference spectra from specific sites under non-resonance conditions.
The RR approach remains the only method available to probe short-lived
species (with half-lives of less than a second down to the picosecond
range), and RR studies on some reactive acyl enzymes exemplify the
detailed structural information that can be obtained. In the late 1970s
and 1980s
,
-unsaturated acyl enzymes of the form
R-C=C-C(=O)-O-chymotrypsin (one of these acyl groups is 5-MTA, seen
in Fig. 1) were good candidates for RR analysis (3, 21-23). These acyl
enzymes are models for the natural acyl enzymes formed during peptide
hydrolysis. The former have absorption maxima near 350 nm, and using
near UV laser sources, RR spectra could be generated of the acyl groups
in the active sites. Moreover, it was possible to obtain spectral data
from the unstable acyl enzymes, prior to deacylation, at high pH in a
rapid mixing rapid flow system. The focus of the work was the RR
feature due to the acyl's C=O group, which could be used to monitor
this group prior to nucleophilic attack in the active site. Three
findings emerged from these studies. 1) As pH was varied, changes in
the C=O stretch region occurred with the same pKa as
that for the deacylation kinetics leading to the conclusion that the
pKa of neighboring His-57 was being probed (24). 2)
At high pH, a linear relationship was found between the position of the
C=O stretch and the log of the deacylation rate constant (25). It
extends over a change in rate constant of 17,000-fold. Moreover, an
empirical relationship between C=O frequency and bond length could be
used to follow C=O bond length changes of the order of 0.001-0.01 Å.
This approach relies on setting up accurate structure-spectra
correlations on a series of "small" model compounds (in this case
generated by IR and x-ray studies on crystals of cyclic and
heterocyclic organic compounds (26)) and then using these to interpret
the changes seen in the (resonance) Raman spectra in terms of
exquisitely accurate structural definition. 3) Shifts in the C=O
stretch were postulated to be because of changes in the active site
-C=O hydrogen bonding strengths, and this effect, too, may be
quantitated. By undertaking H-bonding studies, e.g.
involving the ester of the compound seen in Fig. 1 in CCl4,
with a number of hydrogen bond donors, it is possible to derive a
relationship between the shift in the C=O stretch and the strength of
the hydrogen bond(s) to it. Across the present series of acyl enzymes,
the enthalpy of hydrogen bonding changes by 57 kJ mol
1
(27, 28).
| |
Evolving Technology Increases Applications in Enzymology |
|---|
|
|
|---|
The work discussed above on acyl serine proteases utilized near UV
lasers operating near 350 nm to generate RR spectra of the bound acyl
groups. The spectra were recorded using double or triple monochromators
(to separate the "Raman" from the interfering "Rayleigh"
photons) and detected by a single photomultiplier or, later, an optical
multichannel analyzer. Encouraged by the relationship cited above,
attempts were made to extend the studies to acyl cysteine proteases,
e.g. R-C=C-C(=O)-S-papain, and to other
,
-unsaturated thiol esters such as hexadienoyl-CoA binding to
enoyl-CoA hydratase (29). Again these acyl groups have absorption
features near 350 nm and are candidates for RR studies. However,
satisfactory spectra could not be obtained from these systems because
,
-unsaturated thiol esters are highly photolabile, and the
samples underwent uncontrolled photoisomerization and decomposition in
the laser beam used to generate the RR data. Technical innovations came to the rescue; a combination of efficient holograph-based optical filters to block the Rayleigh photons and high quantum efficiency charge-coupled device photon detectors increased the sensitivity of
Raman instrumentation dramatically (6). In practical terms this meant
that it was no longer necessary to use the resonance condition. For
example, high quality Raman data were obtainable using excitation near
500 or 650 nm. This is far removed from any absorption peak, and thus
the samples are not photochemically modified by the laser beam
(30).
To observe the Raman spectrum of the bound ligand, Raman difference
spectroscopy was employed where the spectrum of the enzyme is
subtracted from the spectrum of the enzyme-ligand complex (31, 32). The
resultant difference spectrum contains features due to the bound ligand
with the possibility of some protein modes appearing if there are
conformational changes occurring upon ligand binding. Ligands such as
the 5-MTA seen in Fig. 1 are strong Raman scatterers (they give rise to
relatively intense Raman signals even under non-resonance conditions)
because of the extended and polarizable
-electron system. For this
reason the ligand modes dominate the difference spectrum. When
experiments involve ligands that scatter less intensely, protein
features appear in the difference spectrum in both the positive and
negative directions, and these are a source of information on changes
in protein structure, although the interpretation of many of these
features is still in its infancy (33, 34).
The Raman difference spectra for acyl cysteine proteases, supported by
absorption spectral data, provided different insights from those
uncovered for the serine analogs (11, 35). Principally, these involve
so-called
-electron polarization; in the cysteine protease active
sites there are strong electrostatic forces that bring about a major
rearrangement of the
-electrons in the acyl group. An
-helix
dipole, terminating at the active site cysteine, is likely one of the
important factors causing polarization of the acyl group's electrons,
and it was proposed that the dipole, with its positive pole pointing
toward the acyl C=O, functions to stabilize negative charge build-up in
the transition state (11).
Ideas on active site-induced electron polarization have been further
refined by Raman difference studies on acyl enzymes involving the
semi-synthetic enzymes, thiol and selenol subtilisins (36). The Raman
data for these 5-MTA acyl enzymes showed that the acyl group
experiences no polarization in the active sites. However, when the
active sites are enlarged, e.g. in selenol subtilisin by
replacing asparagine 155 by a glycine residue, a new conformational state is detected, and this second conformer is polarized. Thus, the
acyl group is able to switch from a region of null electric field to
one where strong electrostatic forces come into play. Using the
x-ray-derived structure of selenol subtilisin combined with modeling
studies (13, 36), it was possible to provide a molecular explanation
for the polarized and non-polarized forms of the acyl groups observed
by spectroscopy. In essence, the additional room in the active site,
created by making the Gly-155 mutant, allows the acyl group to
"flip" about its =C-C=O single bond. Then, it goes from an
environment where it experiences minimal electrostatic forces to one
where there is a negatively charged side chain near the thienyl ring
and strong electropositive effects at the carbonyl because of hydrogen
bonds and an
-helix dipole. Thus, optimum polarization appears to be
achieved by a combination of electron "push" and "pull," as
shown in the schematic in Fig. 2.
|
The above discussion focuses on the use of the 5-MTA group to
demonstrate many of the details on structure and chemistry that can be
elicited from Raman data. This molecule was one of the chromophoric
acyl groups developed as RR probes of active sites in early studies. It
is not part of a natural substrate for the enzymes discussed. Now,
however, with the latest generation of highly sensitive Raman
spectrometers and the use of red or deep red excitation to avoid
fluorescence interference, we are able to consider a plethora of
"natural" enzyme-ligand systems. One such involves the enzyme
4-chlorobenzoate-CoA dehalogenase that carries out the transformation
as shown in Reaction 1.
|
Initial attempts to undertake RR studies of dehalogenase-product
complexes were thwarted again by the photolability of the CoA thiol
esters. However, using a Raman difference spectrometer constructed in
1992 (6), red-excited Raman difference data for the product complex
were obtained (37). These showed that the active site of dehalogenase
can bring about a complete reorganization of the benzoyl group's
electrons and, in turn, provided insight into how the difficult
chemical step of replacing the -Cl atom on the ring by an -OH is
achieved. The determinants for this strong polarization in the active
site of dehalogenase (38) are very similar to those found for the
cysteine proteases and shown in Fig. 2. At the benzoyl C=O there is
strong electron pull exerted by two H-bonds and an
-helix dipole
combined with electron push by an aspartate side chain near the
benzoyl's para position.
Even with the 1992 vintage high throughput Raman spectrometer, studies
on dehalogenase complexes were hampered by concentration requirements.
The latter were close to 1 mM and were usually thwarted by
the protein coming out of solution during concentration procedures. However, in 1997 we were able to modify a commercial spectrograph to
optimize its performance for dilute aqueous solutions (7). With this
instrument concentration requirements were lowered to 100-300
µM. Collecting data for dehalogenase complexes reached a
success rate of 100%, and high quality spectra were obtained for
several dozen complexes with different substrate analogs and protein-engineered forms of the enzyme (39). One of these complexes had
the surprising property of evolving with time (40). It involved the
substrate binding to dehalogenase where the catalytically vital group
Asp-145 had been mutated to asparagine. The enzyme was expected to be
unreactive, and yet a series of spectroscopic changes were detected
over a period of several minutes. Fig. 3 shows Raman difference spectra recorded approximately 1, 1.5, 2, and
4.5 min after adding the substrate to the Asn-145 variant. The data
collection time for each spectrum was only 30 s, but the spectral
fingerprints of several species can be identified. Initially (in the
top trace) the peaks at 1586 and 1216 cm
1 show that there is the expected population of the
4-chloro-substrate bound to the active site of the Asn-145 enzyme.
However, this population decays rapidly with time. There is also
evidence at early times for peaks at 1543 and 1490 cm
1,
and detailed analysis (39) shows that these are because of the ionized
(4-O
) form of the product bound to the Asn- 145 enzyme.
After 5 min the spectra cease evolving, and the signature (Fig. 3,
bottom trace) is that of non-ionized product in
the active site of the wild-type enzyme! The combined Raman
and absorption data provide the following explanation for the spectral
changes. Initially, the Asn-145 mutant enzyme contains a trace of the
wild-type enzyme brought about by spontaneous deamidation of the
Asn-145 side chain. The wild-type enzyme catalyzes the formation of
product, which binds in its its ionized form to the large population of
Asn-145 molecules. Thus, early in the time sequence there are
populations of substrate and product binding to the dominant Asn-145
population. However, the ionized product catalyzes the deamidation of
D145N to give the wild-type enzyme. Thus, in a few minutes all the
substrate is converted to product and all the mutant enzyme is
converted to the wild type, and we see the interesting phenomenon of
product catalyzing changes to the enzyme. In general these studies
show: 1) that Raman difference spectra were able to identify species in
a complex evolving reaction and to aid in identifying the reaction mechanism and 2) that transient species (with lifetimes of tens of
seconds or longer) could be identified at the sub-100 µM
level.
|
| |
Limitations and Prospects |
|---|
|
|
|---|
Although there are outstanding examples where the Raman approach
provides important information on large macromolecular structures such
as nucleic acid-protein complexes (41-43) it may find most use in
defining small regions of large complexes. In that sense it complements
techniques such as x-ray crystallography that provide the "big
picture." Another limitation is that, occasionally, samples are
encountered that have high background signals that are difficult to
remove. This is an area of active investigation since the source of the
background is not understood fully. The target molecules most suited
for Raman difference spectroscopy are those that have relatively
intense normal (non-resonance) Raman signals, which usually means that
they have extended
-electron systems because these are polarizable
and give rise to strong Raman scattering. Saturated systems such as
carbohydrates are less amenable for Raman analysis.
Even with the above limitations the prospects are good that Raman spectroscopy will make an increasing impact in structural biology. In the author's own area of interest, involving enzyme complexes, the last few years have seen the Raman technique go from being applicable to a very few systems to being a means of addressing mechanistic questions for a wide array of enzymes. It is now possible to follow changes in co-factor chemistry in detail. For example, flavoproteins have been difficult subjects for Raman investigations because of their intrinsic fluorescence. However, using red or deep red laser excitation, high quality non-resonance Raman data can now be obtained from the isoalloxazine ring system of flavins (32), and these promise to reveal a wealth of information. There are as yet few studies reported involving receptor-ligand complexes; these should appear in the near future. Similarly, the potential for Raman to provide, fairly rapidly, molecular information for a family of ligands binding to a receptor or enzyme target has yet to be exploited. In another application, Raman microscopes permit us to obtain the Raman spectra of microscopic objects under controlled conditions (44). High quality data can be obtained for protein crystals, and "Raman crystallography" has the potential to provide detailed information on complexes in the crystalline as well as the liquid phases and can thus provide a bridge between the results of the crystallographers and solution studies. Improvements in theory and computational power are leading theorists to calculate increasingly sophisticated models of macromolecular binding sites (45, 46), and Raman may have a role in providing benchmarks against which to test the results of calculations.
Finally, will Raman spectroscopy become an important tool in many
biochemistry laboratories as for example CD now is? Perhaps it will not
be as widespread, but it may become an indispensable tool for
scientists interested in the chemistry of many classes of small
molecule-big molecule interactions. The tide is running in its favor,
the cost of instrumentation is falling, experiments are becoming easier
to undertake, and the results are becoming easier to interpret in a
quantitative fashion.
| |
ACKNOWLEDGEMENTS |
|---|
I am indebted to my students and collaborators for contributions to the work discussed in this review and to colleagues for sharing some of their most recent advances.
| |
FOOTNOTES |
|---|
* This minireview will be reprinted in the 1999 Minireview Compendium, which will be available in December, 1999. Research in this laboratory is supported by National Institutes of Health Grants GM 54072 and DK 53053.
To whom correspondence should be addressed: Dept. of Biochemistry,
Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH
44106. Tel.: 216-368-0031; Fax: 216-368-4544; E-mail:
carey@biochemistry. CWRU.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: 5-MTA, 5-methyl thienylacrylic acid; RR, resonance Raman.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Carey, P. R. (1982) Biochemical Applications of Raman and Resonance Raman Spectroscopies , Academic Press, New York |
| 2. | Edsall, J. T. (1936) J. Chem. Phys. 4, 1-6 |
| 3. | Carey, P. R., and Tonge, P. J. (1995) Acc. Chem. Res. 28, 8-13 |
| 4. | Wang, J. H., Xiao, D. G., Deng, H., Webb, M. R., and Callender, R. (1998) Biochemistry 37, 11106-11116[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Deng, H., Wang, J., Callender, R. H., Grammer, J. C., and Yount, R. G. (1998) Biochemistry 37, 10972-10979[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Kim, M., Owen, H., and Carey, P. R. (1993) Appl. Spectrosc. 47, 1780-1783 |
| 7. | Dong, J., Dinakarpandian, D., and Carey, P. R. (1998) Appl. Spectrosc. 52, 1117-1122 |
| 8. | Frisch, M. J. et al., and Pople, J. A. (1995) Gaussian 94 , Gaussian Inc., Pittsburgh, PA |
| 9. | Deng, H., Kurtz, L. C., Rudolf, F. B., and Callender, R. (1998) Biochemistry 37, 4968-4976[Medline] [Order article via Infotrieve] |
| 10. | Deng, H., and Callender, R. (1998) J. Am. Chem. Soc. 120, 7730-7737[CrossRef] |
| 11. | Doran, J. D., and Carey, P. R. (1996) Biochemistry 35, 12495-12502[Medline] [Order article via Infotrieve] |
| 12. | Dinakarpandian, D., Shenoy, B., Pusztai-Carey, M., Malcolm, B. A., and Carey, P. R. (1997) Biochemistry 36, 4943-4948[Medline] [Order article via Infotrieve] |
| 13. | Dinakarpandian, D., and Carey, P. R. (1999) Biospectroscopy 5, in press |
| 14. | O'Connor, M. J., Dunlap, R. B., Odom, J. D., Hilvert, D., Pusztai-Carey, M., Shenoy, B., and Carey, P. R. (1996) J. Am. Chem. Soc. 118, 239-240[CrossRef] |
| 15. | Kitagawa, T., and Mizutani, Y. (1994) Coordination Chemistry Rev. 135/136, 685-735[CrossRef] |
| 16. | Blackwood, M. E., Rush, T. S., III, Romesberg, F., Schultz, P. G., and Spiro, T. G. (1998) Biochemistry 37, 779-782[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Hu, S., Smith, K. M., and Spiro, T. G. (1996) J. Am. Chem. Soc. 118, 12638-12646[CrossRef] |
| 18. | Dong, S., and Spiro, T. G. (1998) J. Am. Chem. Soc. 120, 10434-10440[CrossRef] |
| 19. | Kitagawa, T., and Ogura, T. (1997) Prog. Inorg. Chem. 45, 431-479 |
| 20. | Lednev, I. K., Karnoup, A. S., Sparrow, M. C., and Asher, S. A. (1999) J. Am. Chem. Soc. 121, 4076-4077[CrossRef] |
| 21. | MacClement, B. A., Carriere, R. G., Phelps, D. J., and Carey, P. R. (1981) Biochemistry 20, 3438-3447[Medline] [Order article via Infotrieve] |
| 22. | Phelps, D. J., Schneider, H., and Carey, P. R. (1981) Biochemistry 20, 3447-3454[Medline] [Order article via Infotrieve] |
| 23. | Carey, P. R., and Phelps, D. J. (1983) Can. J. Chem. 61, 2590-2595 |
| 24. | Tonge, P. J., and Carey, P. R. (1989) Biochemistry 28, 6701-6709[Medline] [Order article via Infotrieve] |
| 25. | Tonge, P. J., and Carey, P. R. (1990) Biochemistry 29, 10723-10727[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Horvath, G., Illenyi, J., Pusztay, L., and Simon, K. (1987) Acta Chim. Hung. 124, 819-822 |
| 27. | Tonge, P. J., and Carey, P. R. (1992) Biochemistry 31, 9122-9125[Medline] [Order article via Infotrieve] |
| 28. | Tonge, P. J., Fausto, R., and Carey, P. R. (1996) J. Mol. Struct. 379, 135-142[CrossRef] |
| 29. | Tonge, P. J., Anderson, V. E., Fausto, R., Kim, M., Pusztai-Carey, M., and Carey, P. R. (1995) Biospectroscopy 1, 387-394 |
| 30. | Tonge, P. J., Carey, P. R., Callender, R., Deng, H., Ekiel, I., and Muhandiram, D. R. (1993) J. Am. Chem. Soc. 115, 8757-8762 |
| 31. | Callender, R., and Deng, H. (1994) Annu. Rev. Biophys. Biomol. Struct. 23, 215-245[Medline] [Order article via Infotrieve] |
| 32. | Kim, M., and Carey, P. R. (1993) J. Am. Chem. Soc. 115, 7015-7016[CrossRef] |
| 33. | Clarkson, J., Jaffe, E. K., Petrovich, R. M., and Carey, P. R. (1997) J. Am. Chem. Soc. 119, 11556-11557[CrossRef] |
| 34. | Clarkson, J., Palfey, B. A., and Carey, P. R. (1997) Biochemistry 36, 12560-12566[Medline] [Order article via Infotrieve] |
| 35. | Doran, J. D., Tonge, P. J., Mort, J. S., and Carey, P. R. (1996) Biochemistry 35, 12487-12494[Medline] [Order article via Infotrieve] |
| 36. | Dinakarpandian, D., Shenoy, B. C., Hilvert, D., McRee, D., McTigue, M., and Carey, P. R. (1999) Biochemistry 38, 6659-6667[Medline] [Order article via Infotrieve] |
| 37. | Taylor, K., Liu, R. Q., Liang, P. H., Price, J., Dunaway-Mariano, D., Tonge, P. J., Clarkson, J., and Carey, P. R. (1995) Biochemistry 34, 13881-13888[Medline] [Order article via Infotrieve] |
| 38. | Benning, M. M., Taylor, K. L., Liu, R., Yang, G., Xiang, H., Wesenberg, G., Dunaway-Mariano, D., and Holden, H. M. (1996) Biochemistry 35, 8103-8109[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Dong, J., Xiang, H., Luo, L., Dunaway-Mariano, D., and Carey, P. R. (1999) Biochemistry 38, 4198-4206[Medline] [Order article via Infotrieve] |
| 40. | Xiang, H., Dong, J., Carey, P. R., and Dunaway-Mariano, D. (1999) Biochemistry 38, 4207-4213[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Laporte, L., and Thomas, G. J., Jr. (1998) Biochemistry 37, 1327-1335[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Laporte, L., Benevides, J. M., and Thomas, G. J., Jr. (1999) Biochemistry 38, 582-588[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Thomas, G. J., Jr. (1999) Annu. Rev. Biophys. Biomol. Struct. 28, 1-27[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Puppels, G. J., de Mul, F. F. M., Otto, C., Greve, J., Robert-Nicoud, M., Arndt-Jovin, D. J., and Jovin, T. (1990) Nature 347, 301-303[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Cunningham, M. A., and Bash, P. A. (1997) Biochimie (Paris) 79, 687-689[Medline] [Order article via Infotrieve] |
| 46. |
Warshel, A.
(1998)
J. Biol. Chem.
273,
27035-27038 |
This article has been cited by other articles:
![]() |
B. F. Brehm-Stecher and E. A. Johnson Single-Cell Microbiology: Tools, Technologies, and Applications Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 538 - 559. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |